EAVI2020: The Quest for an HIV Vaccine

December 02, 2022

The project brought together 22 teams with different expertise and ideas from across Europe, with additional partners in Australia and Canada, to further progress towards an HIV vaccine. You may wonder how a project would even start to approach a problem like developing an HIV vaccine. In a previous study, we found specific regions of HIV, responses to which were associated with low virus load, so we combined them into a singular construct to test in a vaccine.’Test and analysisDeveloping vaccine candidates is just one step towards an effective HIV vaccine. The many data produced by EAVI2020, and the data still to come, are vital to making progress towards an effective HIV vaccine. ‘The HIV vaccine field is beginning to struggle for recognition and further funding because of a false feeling that HIV has been solved by antiretroviral treatment,’ said Professor Hanke.

The source of this news is from University of Oxford